-
公开(公告)号:US20210299739A1
公开(公告)日:2021-09-30
申请号:US16836356
申请日:2020-03-31
Applicant: INSULET CORPORATION
Inventor: Ian MCLAUGHLIN
IPC: B21K1/20
Abstract: Disclosed herein are approaches of forming a component, such as a valve, for a medical device. One approach includes providing a cylinder within a tube, the tube and the cylinder joined together in an interference fit, and annealing the tube and the cylinder, wherein the tube and the cylinder are no longer joined together in the interference fit following the annealing.
-
公开(公告)号:US20210259590A1
公开(公告)日:2021-08-26
申请号:US16796575
申请日:2020-02-20
Applicant: Insulet Corporation
Inventor: Thomas METZMAKER , Nicholas CONTE , Ian MCLAUGHLIN , Joon Bok LEE , Paul Frederick BENTE , Ashutosh ZADE , Steven CARDINALI
Abstract: Disclosed are examples that include receiving information related to ingestion of a meal. The information may include a coarse indication of a size of the meal, a relative time of ingestion of the meal, and a general composition indication of the meal. A blood glucose measurement value received within a predetermined time range of a relative time of ingestion of the meal may be identified. Settings for a delay and an extend parameter and a delivery constraint may be determined. A meal model may be modified using the determined settings for the delay parameter, the extend parameter, and the delivery constraint. The modified meal model may be used to determine a dose of insulin to be delivered in response to the received information. An instruction indicates a determined dose of insulin to be delivered may be output for delivery to a drug delivery device.
-
公开(公告)号:US20200025310A1
公开(公告)日:2020-01-23
申请号:US16514183
申请日:2019-07-17
Applicant: Insulet Corporation
Inventor: Ian MCLAUGHLIN , Daniel ALLIS
Abstract: Disclosed are examples of valve systems and methods of operating the respective valve systems. An example valve system may include a valve body, an inlet component, an outlet component and a valve tube. The valve body may include a first void and a second void. The inlet component may be coupled to the first void and the outlet component may be coupled to the second void. The valve tube may include a side port and may be positioned through the valve body and coupled to the first void, the inlet component, the second void, and the outlet component. Other valve system examples may include including a valve body, a first septum, a second septum, a first piston, a second piston and a tube. The disclosed methods describe the interaction of the respective components of the respective valve system example.
-
4.
公开(公告)号:US20190175832A1
公开(公告)日:2019-06-13
申请号:US16279996
申请日:2019-02-19
Applicant: Insulet Corporation
Inventor: Ian MCLAUGHLIN
Abstract: The present disclosure relates generally to the field of drug delivery. In particular, the present disclosure relates to a drug delivery system that includes a sealed and sterile fluid path attached to a drug-loaded container. The disclosure further relates to methods for sterilizing a portion of the drug delivery system without exposing the drug-loaded container to harmful sterilization parameters.
-
公开(公告)号:US20190091417A1
公开(公告)日:2019-03-28
申请号:US16140178
申请日:2018-09-24
Applicant: INSULET CORPORATION
Inventor: Maureen MCCAFFREY , Ian MCLAUGHLIN
Abstract: A needle mechanism module for automatically inserting a fluid path into a patient for drug delivery is provided. The needle mechanism module can be a component of a wearable drug delivery device. The needle mechanism module can insert a needle and cannula into the patient responsive to activation of the drug delivery device by a user. After insertion, the needle can be automatically retracted, leaving only the cannula in the patient. As a result, discomfort of the user is reduced.
-
公开(公告)号:US20190091416A1
公开(公告)日:2019-03-28
申请号:US16140165
申请日:2018-09-24
Applicant: Insulet Corporation
Inventor: David NAZZARO , Ian MCLAUGHLIN , Jeff BARNES , Daniel ALLIS
Abstract: A wearable drug delivery device that can deliver a liquid drug stored in a container to a patient is provided. The container can be a prefilled cartridge that can be loaded into the drug delivery device by the patient or that can be preloaded within the drug delivery device when provided to the patient. A sealed end of the container is pierced to couple the stored liquid drug to a needle conduit that is coupled to a needle insertion component that provides access to the patient. A drive system of the drug delivery device can expel the liquid drug from the cartridge to the patient through the needle conduit. The drive system can include a spring coupled to a plurality of force transfer elements. The force transfer elements can have a variety of shapes and configurations.
-
公开(公告)号:US20230063696A1
公开(公告)日:2023-03-02
申请号:US18045739
申请日:2022-10-11
Applicant: INSULET CORPORATION
Inventor: David NAZZARO , Ian MCLAUGHLIN , Daniel ALLIS , Simon KOZIN , Maureen MCCAFFREY
Abstract: Systems and methods for monitoring an operational state and/or a fill status of a drug container of a drug delivery device are provided. The drug container can hold a liquid drug. A plunger can be positioned within the drug container. A drive system can advance the plunger to expel the liquid drug from the container. A monitoring system can detect a movement and/or a position of the plunger and/or any component coupled to the plunger. The detection can enable determination of an amount of liquid drug that has been expelled and/or an amount of liquid drug remaining in the drug container. Dosing rates, flow rates, and dosage completion can also be determined.
-
公开(公告)号:US20220218898A1
公开(公告)日:2022-07-14
申请号:US17569965
申请日:2022-01-06
Applicant: Insulet Corporation
Inventor: David NAZZARO , Ian MCLAUGHLIN , Steven CARDINALI , Alexander DOUDOUMOPOULOS
IPC: A61M5/142
Abstract: An improved wearable drug delivery device and method for removal are provided. In some embodiments, a device may include a device body coupled to an adhesive layer, and a removal element coupled to the adhesive layer. The removal element may include an end section proximate a perimeter of the adhesive layer and a central section connected to the end section, wherein a force applied to the end section causes the central section to transition from a first configuration to a second configuration.
-
公开(公告)号:US20220163024A1
公开(公告)日:2022-05-26
申请号:US17667135
申请日:2022-02-08
Applicant: Insulet Corporation
Inventor: Daniel ALLIS , Ian MCLAUGHLIN , Kenneth Phillips
IPC: F04B19/00 , F04B1/02 , F04B53/10 , F04B1/047 , F04B1/0452 , F04B7/00 , F04B9/06 , F04B19/22 , F04B23/02
Abstract: A low-force, non-displacement, micro/miniature valve and/or pump assembly is provided. A tube component having a first side port coupled to an inlet portion and a second side port coupled to an outlet portion can be selectively moved to alternatively couple the side ports to a first or second piston pump chamber. First and second pistons can be actuated after positioning the tube component to either draw in fluid or push out fluid from either the first or second piston pump chambers during each actuation of the pistons. The fluid can be drawn in from a reservoir and can be expelled to a patient for providing a dose of the fluid to the patient.
-
公开(公告)号:US20220096746A1
公开(公告)日:2022-03-31
申请号:US17545256
申请日:2021-12-08
Applicant: Insulet Corporation
Inventor: David NAZZARO , John D`ARCO , Jason O'CONNOR , Ian MCLAUGHLIN
Abstract: A drug delivery system having a drug delivery device and an associated sensor is provided. The sensor can be associated with a sensing site on user. The drug delivery device can be positioned over the sensor in any rotational position and can be associated with an infusion site on the user. The close positioning of the sensor and the drug delivery device allows data from the sensor to be relayed to the drug delivery device and then on to a remote control device. Further, the drug delivery device can be replaced at the end of its duration of use, which is shorter than the duration of use of the sensor, without disturbing the sensor. Subsequent drug delivery devices can then be used with the sensor while allowing each corresponding infusion site to be changed, thereby providing more efficient operation of the drug delivery system.
-
-
-
-
-
-
-
-
-